Similar articles for PMID: 18524974

Year	Number of Results
2003	2
2004	1
2005	6
2006	5
2007	5
2008	16
2009	16
2010	7
2011	11
2012	7
2013	8
2014	5
2015	4
2016	5
2017	6
2018	6
2020	2
2021	3
2024	0

1

No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium.

Langner S, Stumpe S, Kirsch M, Petrik M, Hosten N. Langner S, et al. AJNR Am J Neuroradiol. 2008 Sep;29(8):1525-9. doi: 10.3174/ajnr.A1164. Epub 2008 Jun 4. AJNR Am J Neuroradiol. 2008. PMID: 18524974 Free PMC article. Clinical Trial.

2

The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.

Thomsen HS, Morcos SK, Erley CM, Grazioli L, Bonomo L, Ni Z, Romano L; Investigators in the Abdominal Computed Tomography: IOMERON 400 Versus VISIPAQUE 320 Enhancement (ACTIVE) Study. Thomsen HS, et al. Invest Radiol. 2008 Mar;43(3):170-8. doi: 10.1097/RLI.0b013e31815f3172. Invest Radiol. 2008. PMID: 18301313 Clinical Trial.

3

Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.

Nguyen SA, Suranyi P, Ravenel JG, Randall PK, Romano PB, Strom KA, Costello P, Schoepf UJ. Nguyen SA, et al. Radiology. 2008 Jul;248(1):97-105. doi: 10.1148/radiol.2481071484. Epub 2008 May 15. Radiology. 2008. PMID: 18483232 Clinical Trial.

4

Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.

Barrett BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G, Heiken JP, Lepanto L, Ni ZH, Ni ZH, Nelson R. Barrett BJ, et al. Invest Radiol. 2006 Nov;41(11):815-21. doi: 10.1097/01.rli.0000242807.01818.24. Invest Radiol. 2006. PMID: 17035872 Clinical Trial.

5

Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.

Mehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Kim YH, Fahy M, Dangas GD. Mehran R, et al. JACC Cardiovasc Interv. 2009 May;2(5):415-21. doi: 10.1016/j.jcin.2009.03.007. JACC Cardiovasc Interv. 2009. PMID: 19463464 Free article. Clinical Trial.

6

Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.

Shin DH, Choi DJ, Youn TJ, Yoon CH, Suh JW, Kim KI, Cho YS, Cho GY, Chae IH, Kim CH. Shin DH, et al. Am J Cardiol. 2011 Jul 15;108(2):189-94. doi: 10.1016/j.amjcard.2011.03.019. Epub 2011 May 3. Am J Cardiol. 2011. PMID: 21545991 Clinical Trial.

7

Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.

Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH. Cheruvu B, et al. J Comput Assist Tomogr. 2007 Jul-Aug;31(4):493-8. doi: 10.1097/rct.0b013e31802e29d9. J Comput Assist Tomogr. 2007. PMID: 17882021

8

Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.

Feldkamp T, Baumgart D, Elsner M, Herget-Rosenthal S, Pietruck F, Erbel R, Philipp T, Kribben A. Feldkamp T, et al. Clin Nephrol. 2006 Nov;66(5):322-30. doi: 10.5414/cnp66322. Clin Nephrol. 2006. PMID: 17140161 Clinical Trial.

9

Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.

Davenport MS, Khalatbari S, Dillman JR, Cohan RH, Caoili EM, Ellis JH. Davenport MS, et al. Radiology. 2013 Apr;267(1):94-105. doi: 10.1148/radiol.12121394. Epub 2013 Jan 29. Radiology. 2013. PMID: 23360737 Free PMC article.

10

Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment.

Becker CR, Reiser MF. Becker CR, et al. Invest Radiol. 2005 Oct;40(10):672-5. doi: 10.1097/01.rli.0000178434.43939.a4. Invest Radiol. 2005. PMID: 16189436 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year